eyeonics, Inc. Named One Of Orange County's Fastest Growing Technology Companies In Deloitte's Technology Fast 50 Program
Published: Oct 11, 2006
ALISO VIEJO, Calif., Oct. 11 /PRNewswire/ -- eyeonics, inc.(TM), the developer and manufacturer of the crystalens(R), the first and only FDA approved accommodating intraocular lens, has been named to Deloitte's prestigious Technology Fast 50 Program for Orange County, California. The Technology Fast 50 is a ranking of the 50 fastest growing technology companies in the area by Deloitte & Touche USA LLP, one of the nation's leading professional services organizations. Rankings are based on the percentage revenue growth over five years from 2001-2005.
This year's Orange County Technology Fast 50 program is co-presented by Deloitte & Touche USA LLP and Porsche Motorsport, Continental Airlines, DLD Insurance, McDermott & Bull, Comerica, Stradling Yocca Carlson & Rauth, Cresa Partners and Merrill Corporation, in association with AeA and the Technology Council of Southern California.
J. Andy Corley, Chairman and CEO of eyeonics, attributes the company's 5596 percent revenue growth to its superior accommodating lens technology. Corley said, "With more than 50,000 crystalenses implanted to date, the accommodating function of the crystalens has emerged as the solution of choice for patients who want improved far, intermediate and near vision without the glare and halos common with multi-focal lenses. As we continue to refine and improve on our core accommodating technology, we are confident that we will maintain our leadership role in the premium IOL channel, and that our growth will continue."
eyeonics' increase in revenues of 5596 percent from 2001 to 2005 resulted in its number two ranking in the Technology Fast 50 for Orange County. The average increase in revenues among companies who made the Technology Fast 50 for this region was 643 percent.
"Deloitte's Orange County Technology Fast 50 companies have shown the strength, vision and tenacity to succeed in today's very competitive technology environment," said Rick Rayson, Managing Partner, Deloitte & Touche LLP in Orange County. "We applaud the successes of eyeonics and acknowledge it as one of the very few to accomplish such a fast growth rate over the past five years."
To qualify for the Technology Fast 50, companies must have had operating revenues of at least $50,000 in 2001 and $5,000,000 in 2005, be headquartered in North America, and be a company that owns proprietary technology or proprietary intellectual property that contributes to a significant portion of the company's operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies' technology or intellectual property in a unique way does not qualify.
Winners of the 16 regional Technology Fast 50 programs in the United States and Canada are automatically entered in Deloitte's Technology Fast 500 program, which ranks North America's top 500 fastest growing technology, media, telecommunications and life sciences companies. For more information on Deloitte's Technology Fast 50 or Technology Fast 500 programs, visit www.fast500.com .
The crystalens is the result of more than 14 years of research and development by J. Stuart Cumming, M.D., F.A.C.S., and was approved by the FDA in November 2003. More than 50,000 lenses have been implanted worldwide. During clinical trials, all of the patients who received the crystalens greatly reduced their need for corrective lenses or eyeglasses. The patented crystalens technology is designed to allow the lens to move in the eye in a manner similar to the natural lens. By using the eye's muscle to move the lens back and forwards naturally, patients can focus through a continuous range of vision including near, far and everywhere in between. All other intraocular lenses are designed to remain fixed in the eye. For more information about the crystalens go to http://www.crystalens.com/ .
About eyeonics, inc.(TM)
eyeonics is a privately held medical device company headquartered in Aliso Viejo, California, founded in 1998. eyeonics is committed to developing a new class of visual enhancement systems that will enable patients to see up close, far away and all distances in between. For more information about eyeonics, inc. and the crystalens go to http://www.eyeonics.com/ or http://www.crystalens.com/ .
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte," "Deloitte & Touche," "Deloitte Touche Tohmatsu" or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein.
Deloitte & Touche USA LLP is the US member firm of Deloitte Touche Tohmatsu. In the US, services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte & Touche USA LLP.
Approved by: Steven J. Naber Chief Financial Officer eyeonics, inc. 949-389-1783 Contacts: Steve DiMattia EVC Group, Inc. 646-277-8706eyeonics, inc.
CONTACT: Steve DiMattia of EVC Group, Inc., +1-646-277-8706, for eyeonics,inc.; or Steven J. Naber, Chief Financial Officer, of eyeonics, inc.,+1-949-389-1783